CoChat

A mortality study on male subjects exposed to polyfluoroalkyl acids with high internal dose of perfluorooctanoic acid

Girardi, Paolo, Merler, Enzo · 2019 · Environmental Research
Cited by 118

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

OBJECTIVES The aim of the present study was to examine the association between exposure to polyfluoroalkyl substances (PFASs) and mortality (1970-2018) in a cohort of 462 male employees who had worked at least six months before 2009 for a factory (14,658 person-years; 107 deaths, average follow-up time 31.7 years), which had been producing perfluorooctanoic acid (PFOA), perfluorooctanesulfonyl fluoride (PFOS) and other chemicals since 1968. METHODS Employees were classified as follows: 1) by probability of exposure to PFASs; 2) by tertiles of PFOA serum concentrations. In a fraction (n = 120) of workers measurements of internal PFOA serum concentration were used to predict a cumulative serum PFOA concentration of each cohort member. Mortality rates were compared to that of the regional population using the standardized mortality ratio (SMR), and to that of the workers of a nearby metalworking factory in terms of risk ratio (RR), across categories of probability of PFASs exposure and tertiles of cumulative serum PFOA concentrations. RESULTS Internal PFOA serum concentration among 120 workers in the 2000-2013 period was very high (Geometric Mean: 4048 ng/mL; range 19-91,900 ng/mL). The mortality of the chemical cohort was increased for liver cancer (SMR: 2.32; CI: 1.11-4.87), malignant neoplasm of lymphatic and haematopoietic tissue (SMR: 2.26; CI: 1.08-4.73). In the comparison with the cohort of workers from the metalworking factory, the RRs for mortality of the cohort were increased for overall mortality (RR: 1.42; CI: 1.12-1.79), diabetes (RR: 5.95; CI: 1.08-32.8), liver cancer (RR: 6.69; CI: 1.71-26.2) and liver cirrhosis (RR: 3.87; CI: 1.18-12.7). Mortality for these causes increased in association with probability of PFASs exposure and with tertiles of cumulative PFOA serum concentrations. CONCLUSION The present is a small observational study with limited control over confounding factors. The cohort showed increased mortality for all causes and subjects in the highest cumulative internal dose of PFOA had a statistically significant increase for mortality of liver cancer, liver cirrhosis, diabetes, malignant neoplasms of lymphatic and haematopoietic tissue in both comparisons. Toxicological studies on PFOA and PFOS provide support for causality for the observed association with the risk for liver cirrhosis and liver cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.envres.2019.108743

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 32

  1. Alexander, 2003, Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility, Occup. Environ. Med., 60, 722, 10.1136/oem.60.10.722 · DOI · Paper page
  2. Alexander, 2007, Multiple myeloma: a review of the epidemiologic literature, Int. J. Cancer, 120, 40, 10.1002/ijc.22718 · DOI · Paper page
  3. Axelson, 1980, Aspects of confounding and effect modification in the assessment of occupational cancer risk, J. Toxicol. Environ. Health, 6, 1127, 10.1080/15287398009529933 · DOI · Paper page
  4. Barry, 2013, Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant, Environ. Health Perspect., 121, 1313, 10.1289/ehp.1306615 · DOI · Paper page
  5. Biegel, 2001, Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats, Toxicol. Sci., 60, 44, 10.1093/toxsci/60.1.44 · DOI · Paper page
  6. Burstyn, 2014, Effects of non-differential exposure misclassification on false conclusions in hypothesis-generating studies, Int. J. Environ. Res. Public Health, 11, 10951, 10.3390/ijerph111010951 · doi:10.3390/ijerph111010951
  7. Consonni, 2013, Cancer risk among tetrafluoroethylene synthesis and polymerization workers, Am. J. Epidemiol., 178, 350, 10.1093/aje/kws588 · DOI · Paper page
  8. Crebelli, 2019, Can sustained exposure to PFAS trigger a genotoxicresponse? A comprehensive genotoxicity assessment in mice after subacute oral administration of PFOA and PFBA, Regul. Toxicol. Pharmacol., 106, 169, 10.1016/j.yrtph.2019.05.005 · DOI · Paper page
  9. Darrow, 2016, Modeled perfluorooctanoic acid (PFOA) exposure and liver function in a mid-Ohio valley community, Environ. Health Perspect., 124, 1227, 10.1289/ehp.1510391 · DOI · Paper page
  10. Ferrante, 2017, The working group. Italian pool of asbestos workers cohorts: mortality trends of asbestos-related neoplasms after long time since first exposure, Occup. Environ. Med., 74, 887, 10.1136/oemed-2016-104100 · DOI
  11. Filgo, 2015, Perfluorooctanoic acid (PFOA)–induced liver lesions in two strains of mice following developmental exposures: PPARα is not required, Toxicol. Pathol., 43, 558, 10.1177/0192623314558463 · DOI · Paper page
  12. Franko, 2012, Dermal penetration potential of perfluorooctanoic acid (PFOA) in human and mouse skin, J. Toxicol. Environ. Health, Part A., 75, 50, 10.1080/15287394.2011.615108 · DOI · Paper page
  13. Gallo, 2012, Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure, Environ. Health Perspect., 120, 655, 10.1289/ehp.1104436 · DOI · Paper page
  14. Gao, 2017, Molecularmechanisms of PFOA-induced toxicity in animals and humans: implications for health risks, Environ. Int., 99, 43, 10.1016/j.envint.2016.11.014 · DOI · Paper page
  15. Geiger, 2014, The association between PFOA, PFOS and serum lipid levels in adolescents, Chemosphere, 98, 78, 10.1016/j.chemosphere.2013.10.005 · DOI · Paper page
  16. Girardi, 2017, Mortality study of a cohort of chemical workers producing perfluorinated derivatives and other chemicals, Occup. Environ. Med., 74, A12
  17. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2016, vol. 110
  18. Karnes, 2014, Incidence of type II diabetes in a cohort with substantialexposure to perfluorooctanoic acid, Environ. Res., 128, 78, 10.1016/j.envres.2013.11.003 · DOI
  19. Koller, 2016, Robustlmm: an R package for robust estimation of linear mixed-effects models, J. Stat. Softw., 75, 1, 10.18637/jss.v075.i06 · DOI · Paper page
  20. McGreal, 2016, The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction, Toxicol. Appl. Pharmacol., 1, 18
  21. Olsen, 2005, Historical comparison of perfluorooctanesulfonate, perfluorooctanoate, and other fluorochemicals in human blood, Environ. Health Perspect., 113, 539, 10.1289/ehp.7544 · DOI · Paper page
  22. Paustenbach, 2007, A methodology for estimating human exposure to perfluorooctanoic acid (PFOA): a retrospective exposure assessment of a community (1951–2003), J. Toxicol. Environ. Health, 70, 28, 10.1080/15287390600748815 · DOI · Paper page
  23. Rajamani, 2017, Endocrine disruptors induce perturbations in endoplasmic reticulum and mitochondria of human pluripotent stem cell derivatives, Nat. Commun., 8, 1
  24. Raleigh, 2014, Mortality and cancer incidence in ammonium perfluorooctanoate production workers, Occup. Environ. Med., 71, 500, 10.1136/oemed-2014-102109 · DOI · Paper page
  25. Salihovic, 2018, Changes in markers of liver function in relation to changes in perfluoroalkyl substances - a longitudinal study, Environ. Int., 117, 196, 10.1016/j.envint.2018.04.052 · DOI · Paper page
  26. Steenland, 2012, Cohort mortality study of workers exposed to perfluorooctanoic acid, Am. J. Epidemiol., 15, 909, 10.1093/aje/kws171 · DOI · Paper page
  27. Steenland, 2015, A cohort incidence study of workers exposed to perfluorooctanoic acid (PFOA), Occup. Environ. Med., 72, 373, 10.1136/oemed-2014-102364 · DOI · Paper page
  28. Vieira, 2013, Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis, Environ. Health Perspect., 121, 318, 10.1289/ehp.1205829 · DOI · Paper page
  29. Winquist, 2014, Modeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohorts, Environ. Health Perspect., 122, 1299, 10.1289/ehp.1307943 · DOI · Paper page
  30. Winquist, 2013, Design, methods, and population for a study of PFOA health effects among highly exposed mid-Ohio valley community residents and workers, Environ. Health Perspect., 121, 893, 10.1289/ehp.1206450 · DOI · Paper page
  31. Woskie, 2012, Retrospective exposure assessment of perfluorooctanoic acid serum concentrations at a fluoropolymer manufacturing plant, Ann. Occup. Hyg., 56, 1025, 10.1093/annhyg/mes023 · DOI · Paper page
  32. Wu, 2017, Effect of acute exposure to PFOA on mouse liver cells in vivo and in vitro, Environ. Sci. Pollut. Res., 24, 24201, 10.1007/s11356-017-0072-5 · DOI

Cited by

See all 118

Metadata

Authors
Girardi, P., & Merler, E.
Venue
Environmental Research
Publisher
Elsevier BV
Published
2019-12
Volume
179
Issue
Pt A
Pages
108743
ISSN
0013-9351 (ISSN-L)
OpenAlex
W2972841306
Cited by
118
References
15
FWCI
4.45
Type
journal article
Language
en
Open access
closed
Funders
Regione del Veneto (1191)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.